These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 10675688)
1. Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres. Sah H Int J Pharm; 2000 Feb; 195(1-2):103-13. PubMed ID: 10675688 [TBL] [Abstract][Full Text] [Related]
2. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process. Cho M; Sah H J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886 [TBL] [Abstract][Full Text] [Related]
3. Solvent hydrolysis rate determines critical quality attributes of PLGA microspheres prepared using non-volatile green solvent. Kim H; Kim S; Sah H J Biomater Sci Polym Ed; 2018 Jan; 29(1):35-56. PubMed ID: 29086633 [TBL] [Abstract][Full Text] [Related]
4. Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent. Im HY; Sah H Int J Pharm; 2009 Dec; 382(1-2):130-8. PubMed ID: 19715744 [TBL] [Abstract][Full Text] [Related]
5. Reverse micelle-based microencapsulation of oxytetracycline hydrochloride into poly-d,l-lactide-co-glycolide microspheres. Kim H; Lee BJ; Sah H Drug Deliv; 2007 Feb; 14(2):95-9. PubMed ID: 17364873 [TBL] [Abstract][Full Text] [Related]
6. Nonhalogenated solvent-based solvent evaporation process useful in preparation of PLGA microspheres. Jang J; Sah H J Microencapsul; 2011; 28(6):490-8. PubMed ID: 21827356 [TBL] [Abstract][Full Text] [Related]
7. Investigation on structural integrity of PLGA during ammonolysis-based microencapsulation process. Heo S; Lee M; Lee S; Sah H Int J Pharm; 2011 Oct; 419(1-2):60-70. PubMed ID: 21839820 [TBL] [Abstract][Full Text] [Related]
8. A novel method of preparing PLGA microcapsules utilizing methylethyl ketone. Sah H; Smith MS; Chern RT Pharm Res; 1996 Mar; 13(3):360-7. PubMed ID: 8692726 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of enzyme stability during preparation of polylactide-co-glycolide microspheres. Perugini P; Genta I; Pavanetto F; Modena T; Maculotti K; Conti B J Microencapsul; 2002; 19(5):591-602. PubMed ID: 12433302 [TBL] [Abstract][Full Text] [Related]
10. Application of acid-catalyzed hydrolysis of dispersed organic solvent in developing new microencapsulation process technology. Lee H; Lee S; Bhattacharjee H; Sah H J Microencapsul; 2012; 29(4):380-7. PubMed ID: 22299629 [TBL] [Abstract][Full Text] [Related]
11. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. Wang FJ; Wang CH J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566 [TBL] [Abstract][Full Text] [Related]
12. Modified emulsion solvent evaporation method for fabricating core-shell microspheres. Xiao CD; Shen XC; Tao L Int J Pharm; 2013 Aug; 452(1-2):227-32. PubMed ID: 23694803 [TBL] [Abstract][Full Text] [Related]
13. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. Iwata M; McGinity JW J Microencapsul; 1992; 9(2):201-14. PubMed ID: 1593404 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition. Kwon YM; Kim SW Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317 [TBL] [Abstract][Full Text] [Related]
16. Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process. Shim H; Sah H Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32384751 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery. Haddadi A; Farboud ES; Erfan M; Aboofazeli R J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885 [TBL] [Abstract][Full Text] [Related]
18. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin. Cho SW; Song SH; Choi YW Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588 [TBL] [Abstract][Full Text] [Related]
19. Another paradigm in solvent extraction-based microencapsulation technologies. Im HY; Kim J; Sah H Biomacromolecules; 2010 Mar; 11(3):776-86. PubMed ID: 20131759 [TBL] [Abstract][Full Text] [Related]
20. Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis. Zaghloul AA; Mustafa F; Siddiqui A; Khan M Pharm Dev Technol; 2006; 11(3):377-87. PubMed ID: 16895848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]